Molecular hydrogen alleviates asphyxia-induced neuronal cyclooxygenase-2 expression in newborn pigs.
Viktória Varga, János Németh, Orsolya Oláh, Valéria Tóth-Szűki, Viktória Kovács, Gábor Remzső, Ferenc Domoki · Acta pharmacologica Sinica · 2018
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
Neutral Summary
In an animal model, H₂ treatment essentially prevented the increases in COX-2-immunopositive neurons. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
Study Design and Population
Porcine model
Hydrogen Intervention
Other or not reported
Important Limitations
Preclinical animal findings may not translate directly to human outcomes.
Safety Findings
The abstract did not provide detailed safety or adverse-event information.
Additional Notes
H2HUBB TAKEAWAY
In an animal model, H₂ treatment essentially prevented the increases in COX-2-immunopositive neurons. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. H₂ treatment essentially prevented the increases in COX-2-immunopositive neurons.
What the Researchers Studied
The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
In this study the researchers sought to determine whether COX-2 was induced by asphyxia in newborn pigs, and whether neuronal COX-2 levels were affected by H₂ treatment. Piglets were subjected to either 8 min of asphyxia or a more severe 20 min of asphyxia followed by H₂ treatment (inhaling room air containing 2.1% H₂ for 4 h). H₂ treatment essentially prevented the increases in COX-2-immunopositive neurons.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.